93 results
Page 3 of 5
8-K
EX-10.1
ecl6diezn80 nq
3 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
9r3e1ztpbw6b6
7 Aug 17
AntriaBio and ActiveSite Pharmaceuticals Announce License and Development Agreement for Plasma Kallikrein Inhibitors
12:00am
8-K
EX-10.1
h4mf uzf64dpiv1epn8
6 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.6
fieggva
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.7
481 qrfpp373nfgl
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
naja56 04dfxhe0yre
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
jwbg2
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.4
tvgd0mc
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
cf0l 7fv7fy4rrtmdflg
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.5
vwkigomxyw4zk
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
khulkbarm0ajulf7i5ax
4 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
2amwriqqv 65qopvf0
4 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.4
tb8yjk
29 Jun 16
AntriaBio Announces $12 Million Private Placement
12:00am
8-K
EX-10.1
myfse 5igua2ovbyo6
29 Jun 16
AntriaBio Announces $12 Million Private Placement
12:00am